Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...
Insiders sold more Tempus AI (TEM) stock last week as shares of the medical technology firm continue to notch a series of fresh all-time highs.
CHICAGO—Eric Lefkofsky, CEO and Chairman of Tempus AI , Inc. (NASDAQ:TEM), has recently sold a significant portion of his holdings in the company. According to a filing with the Securities and ...
Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced they will report ...
Experts say Investors may be valuing AI companies too generously if health systems can’t justify the costs of these tools.
Up about 12%, Tempus AI (NASDAQ:TEM) has been explosive. Helping, its volume just spiked to 18.6 million shares, as compared ...
The company’s quarterly earnings will be released the same day. The call will feature Tempus Founder and CEO, Eric Lefkofsky, and Chief Financial Officer, Jim Rogers. The live audio webcast will ...
And, according to Eric Lefkofsky, Founder and CEO of Tempus, the acquisition “complements our strategy of leveraging diagnostics and data to drive innovation, further strengthening our ability ...
In a regulatory filing on Friday, Tempus AI (TEM) disclosed that Chairman and CEO Eric Lefkofsky sold a series of shares beginning on January 22, totaling about $62M. On January 22, Lefkofsky sold ...